Bimodal Imaging-Guided Temporal Optimization of Combined Chemotherapy and DC Vaccine Immunotherapy
RNA-seq (gene expression) · mouse · 45 samples
- What it is
- RNA-seq (gene expression)Gene activity measured by sequencing. The summary does not mention single-cell work, so this is most likely bulk: one average per sample, the usual starting point for comparing groups.
- Organism
- Mus musculus (mouse)
- Samples
- 45 samples: 30 distinct titles, 7 of them repeatedGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
Read the full summary ↓
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE325822_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: For RNA-seq the counts are usually a table among the supplementary files (look for 'counts', 'expression', 'FPKM' or 'TPM' in the file name). The series matrix of a sequencing study is sometimes nearly empty.
Also filed as BioProject PRJNA1442016 and SRA study SRP686205. Searching any of these in the dataset finder brings you back here.
How we read this: Read from 45 sample titles: 30 distinct titles with little repetition. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM9613930 mouse-PLN,ICD,d3_1
- GSM9613931 mouse-PLN,ICD,d7_1
- GSM9613932 mouse-PLN,ICD,d10_1
- GSM9613933 mouse-PLN,ICD,d14_1
- GSM9613934 mouse-FLN,ICD,d3_1
- GSM9613935 mouse-FLN,ICD,d7_1
- GSM9613936 mouse-FLN,ICD,d10_1
- GSM9613937 mouse-FLN,ICD,d14_1
- GSM9613938 mouse-PLN,OD3_1
- GSM9613939 mouse-PLN,OD7_1
- GSM9613940 mouse-PLN,OD10_1
- GSM9613941 mouse-PLN,OD14_1
- GSM9613942 mouse-PLN,OD14_2
- GSM9613943 mouse-FLN,OD3_1
- GSM9613944 mouse-FLN,OD7_1
- GSM9613945 mouse-FLN,OD10_1
- GSM9613946 mouse-FLN,OD14_1
- GSM9613947 mouse-PLN,YF,d3_1
- GSM9613948 mouse-PLN,YF,d7_1
- GSM9613949 mouse-PLN,YF,d10_1
- GSM9613950 mouse-PLN,YF,CON_1
- GSM9613951 mouse-FLN,YF,d3_1
- GSM9613952 mouse-FLN,YF,d7_1
- GSM9613953 mouse-FLN,YF,d10_1
- GSM9613954 mouse-FLN,YF,CON_1
- GSM9613955 mouse-tumor,CON_1
- GSM9613956 mouse-tumor,CON_4
- GSM9613957 mouse-tumor,CON_5
- GSM9613958 mouse-tumor,DC_2
- GSM9613959 mouse-tumor,DC_3
- GSM9613960 mouse-tumor,DC_4
- GSM9613961 mouse-tumor,DC_5
- GSM9613962 mouse-tumor,OXA_1
- GSM9613963 mouse-tumor,OXA_2
- GSM9613964 mouse-tumor,OXA_3
- GSM9613965 mouse-tumor,OD3_1
- GSM9613966 mouse-tumor,OD3_2
- GSM9613967 mouse-tumor,OD3_3
- GSM9613968 mouse-tumor,OD3_4
- GSM9613969 mouse-tumor,OD7_1
+ 5 more — browse all 45 samples with per-sample file links →
- GSE249630 Modeling T cell temporal response to cancer immunotherapy rationalize development of combinatorial treatments protocols 1372 samples shares immunotherapy, temporal
- GSE264527 Reshaping the Tumor Microenvironment of KRASG12D Pancreatic Ductal Adenocarcinoma with combined SOS1 and MEK Inhibition for Improved Immunotherapy Response 21 samples shares immunotherapy, combined
- GSE263386 SFRP2+ CAFs Hinder Abscopal Effect from Combined Radiotherapy and Immunotherapy by Forming a Hostile Perivascular Niche [II] 15 samples shares immunotherapy, combined
- GSE215960 Subclonal evolution revealed by single-cell profiles of expressed mutations identifies adaptation mechanisms to immunotherapy in melanoma [scRNA-seq] 192 samples shares immunotherapy
- GSE302715 A tumor-associated macrophage-targeted immunocytokine leveraging T and NK cell synergy for potent cancer immunotherapy [scRNA-seq] 187 samples shares immunotherapy
- GSE342349 CT26 multi-tissue RNA-seq under immunotherapy combinations 72 samples shares immunotherapy
- GSE196790 Nucleotide metabolism in cancer cells fuels a UDP-driven macrophage cross-talk promoting immunosuppression and immunotherapy resistance 54 samples shares immunotherapy
- GSE240708 Degenerative and regenerative peripheral processes are associated with persistent painful chemotherapy-induced neuropathies in males and females 53 samples shares chemotherapy
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.